Aktien Sensor

Lonza’s stock price has experienced significant growth over the past decade, driven by the increasing demand for high-potency active pharmaceutical ingredients and the company’s commitment to innovation and quality.

Lonza’s stock price has plummeted over the past three years, leaving investors with significant losses, despite the company’s substantial market value of 42 billion Swiss francs.

Lonza’s stock price has plummeted over the past three years, leaving investors with significant losses, and raising questions about the company’s leadership and future prospects.